Table 4.

Combination index values for the apoptotic effects of doxorubicin and Nutlin-3a




Sequence*

ED50

ED75

ED90

ED95

Averaged CI
OCI-AML-3       
    Sample 1   DOX + 3a   0.76   0.67   0.60   0.55   0.65  
    Sample 2   DOX →3a   0.89   0.84   0.80   0.79   0.83  
    Sample 3   3a → DOX   0.81   0.82   0.83   0.84   0.83  
MOLM-13       
    Sample 1   DOX + 3a   0.91   0.57   0.39   0.32   0.55  
    Sample 2   DOX → 3a   0.80   0.73   0.66   0.62   0.70  
    Sample 3   3a → DOX   0.75   0.60   0.48   0.42   0.56  
Primary AML       
    No. 1   DOX + 3a   0.84   0.81   0.80   0.79   0.81  
    No. 2   DOX + 3a   0.85   0.83   0.81   0.80   0.82  
Normal CD34+       
    No. 1   DOX + 3a   1.10   1.18   1.26   1.32   1.22  
    No. 2   DOX + 3a   1.46   1.27   1.13   1.05   1.23  
    No. 3
 
DOX + 3a
 
0.76
 
0.90
 
1.10
 
1.27
 
1.01
 



Sequence*

ED50

ED75

ED90

ED95

Averaged CI
OCI-AML-3       
    Sample 1   DOX + 3a   0.76   0.67   0.60   0.55   0.65  
    Sample 2   DOX →3a   0.89   0.84   0.80   0.79   0.83  
    Sample 3   3a → DOX   0.81   0.82   0.83   0.84   0.83  
MOLM-13       
    Sample 1   DOX + 3a   0.91   0.57   0.39   0.32   0.55  
    Sample 2   DOX → 3a   0.80   0.73   0.66   0.62   0.70  
    Sample 3   3a → DOX   0.75   0.60   0.48   0.42   0.56  
Primary AML       
    No. 1   DOX + 3a   0.84   0.81   0.80   0.79   0.81  
    No. 2   DOX + 3a   0.85   0.83   0.81   0.80   0.82  
Normal CD34+       
    No. 1   DOX + 3a   1.10   1.18   1.26   1.32   1.22  
    No. 2   DOX + 3a   1.46   1.27   1.13   1.05   1.23  
    No. 3
 
DOX + 3a
 
0.76
 
0.90
 
1.10
 
1.27
 
1.01
 
*

Doxorubicin (DOX) and Nutlin-3a (3a) were administered simultaneously (DOX+3a) or sequentially with a 24-hour interval (DOX→3a or 3a→DOX).

The averaged combination index (CI) values were calculated from the ED50, Ed75, ED90, and ED95.

Close Modal

or Create an Account

Close Modal
Close Modal